Literature DB >> 12459650

Use of and beliefs about dermoscopy in the management of patients with pigmented lesions: a survey of dermatology residency programmes in the United States.

K S Nehal1, S A Oliveria, A A Marghoob, P J Christos, S W Dusza, J S Tromberg, A C Halpern.   

Abstract

Dermoscopy is a non-invasive technique that can be utilized for the clinical diagnosis of pigmented lesions. The aim of this study was to assess the utilization and beliefs about the usefulness of dermoscopy in the evaluation of pigmented lesions by physicians in dermatology residency programmes, and to determine the extent of dermoscopy training received by residents in these programmes. Questionnaires were sent to the directors of all the accredited dermatology residency programmes in the United States (n = 105). A follow-up postcard questionnaire was sent to the chief resident of all the responding programmes. Eighty-three physicians responded to the questionnaire (79%). Fifty-one per cent of the respondents (n = 42) reported utilizing dermoscopy. Reported reasons for using dermoscopy by respondents included the fact that it helps detect melanoma early (74%), leads to fewer biopsies (74%) and reduces patient anxiety (64%). Lack of training (51%) and lack of usefulness (42%) were amongst the reported reasons for not utilizing dermoscopy. Sixty-seven per cent of respondents reported an increase of approximately 50% in the use of dermoscopy over the past 5 years, and 45% anticipated an increase in use over the next 5 years. Thirty-eight per cent of chief residents from the responding programmes reported receiving training in dermoscopy during residency. In conclusion, half of the dermatology residency programmes currently use dermoscopy in the evaluation of pigmented lesions. The main reason for not using dermoscopy was a lack of training. Respondents anticipated a future increase in the use of dermoscopy.

Entities:  

Mesh:

Year:  2002        PMID: 12459650     DOI: 10.1097/00008390-200212000-00010

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  6 in total

1.  Rates of Dermoscopy Use for Melanoma Diagnosis in the Miami VA Medical Center.

Authors:  Lucy L Chen; Erin X Wei; Fangchao Ma; Jonette Keri; Shasa Hu
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

Review 2.  Current and emerging technologies in melanoma diagnosis: the state of the art.

Authors:  Estee L Psaty; Allan C Halpern
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

3.  Clinical Perspective of 3D Total Body Photography for Early Detection and Screening of Melanoma.

Authors:  Jenna E Rayner; Antonia M Laino; Kaitlin L Nufer; Laura Adams; Anthony P Raphael; Scott W Menzies; H Peter Soyer
Journal:  Front Med (Lausanne)       Date:  2018-05-23

4.  Analysis of dermoscopy teaching modalities in United States dermatology residency programs.

Authors:  Yun An Chen; Joanne Rill; Elizabeth V Seiverling
Journal:  Dermatol Pract Concept       Date:  2017-07-31

5.  The need for improved dermoscopy training in residency: a survey of US dermatology residents and program directors.

Authors:  Parth Patel; Sarika Khanna; Beth McLellan; Karthik Krishnamurthy
Journal:  Dermatol Pract Concept       Date:  2017-04-30

6.  Triage amalgamated dermoscopic algorithm (TADA) for skin cancer screening.

Authors:  Tova Rogers; Maria Marino; Stephen W Dusza; Shirin Bajaj; Michael A Marchetti; Ashfaq Marghoob
Journal:  Dermatol Pract Concept       Date:  2017-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.